BIOMAT Database Logo BIOMAT Database Logo

[General summary and conclusions]. 2010

José Campos, and Francesc Gudiol
Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, España. jcampos@isciii.es

UI MeSH Term Description Entries
D004363 Drug Utilization The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles. Utilization, Drug,Drug Utilizations,Utilizations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

José Campos, and Francesc Gudiol
Summary of General Discussion and Conclusions.
March 2018, Advances in dental research,
José Campos, and Francesc Gudiol
Summary and conclusions.
January 2012, Progress in molecular biology and translational science,
José Campos, and Francesc Gudiol
Summary and conclusions.
January 1956, Clinical orthopaedics,
José Campos, and Francesc Gudiol
[Summary and conclusions].
March 2003, Annales pharmaceutiques francaises,
José Campos, and Francesc Gudiol
Summary and conclusions.
January 1966, Bulletin of the World Health Organization,
José Campos, and Francesc Gudiol
Summary and conclusions.
October 2005, The American journal of cardiology,
José Campos, and Francesc Gudiol
Summary and conclusions.
April 1980, Aktuelle Gerontologie,
José Campos, and Francesc Gudiol
Conclusions and summary.
December 1974, Documenta ophthalmologica. Advances in ophthalmology,
José Campos, and Francesc Gudiol
Summary and Conclusions.
July 2015, High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension,
José Campos, and Francesc Gudiol
[Summary and conclusions].
January 1978, Haematology and blood transfusion,
Copied contents to your clipboard!